Presentation to Bell Potter Healthcare Conference
Filed with ASX · · 44 pages · English
Melbourne, Australia, 13 November 2023: Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) is pleased to provide a copy of the presentation to be delivered by Dr Andreas Fouras, Managing Director and CEO of 4DMedical, to the Bell Potter Healthcare Conference on 14 November 2023. –ENDS– Authorised by the 4DMedical Board of Directors. Contacts Corporate
In the deck
Earlier from 4DMedical
- U.S. CMS Approves Reimbursement for 4DMedical
- Quarterly Activity Report and Appendix 4C for Q1 FY2024
- 4DMedical enters contract with Integral Diagnostics
- Investor Presentation
- S&P DJI Announces September 2023 Quarterly Rebalance
Later from 4DMedical
- 4DMedical receives U.S. FDA clearance for CT LVAS
- 4DX signs SaaS contracts to expand into Detroit & Memphis
- 4DMedical and Philips sign Memorandum of Understanding
- Webinar presentation
- S&P DJI Announces December 2023 Quarterly Rebalance
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical